“FDA Provides Perspective on Goals and Challenges for Regulation of Artificial Intelligence in Medical Devices, Drug Design, and Clinical Research.” Read our latest Life Sciences Blog post by Doug Crandell and Joe Mallon here: https://lnkd.in/gXkfRjgA #KnobbeMartens #IPLaw #LifeSciences #Biotechnology
